Literature DB >> 9581851

Elevated cyclins and cyclin-dependent kinase activity in the rhabdomyosarcoma cell line RD.

E S Knudsen1, C Pazzagli, T L Born, B L Bertolaet, K E Knudsen, K C Arden, R R Henry, J R Feramisco.   

Abstract

An important early event in the differentiation of skeletal muscle cells is exit from the cell cycle, after which full expression of the muscle phenotype occurs. Rhabdomyosarcoma (RMS), a tumor of skeletal muscle origin, expresses a number of muscle-specific proteins, including MyoD; however, these cells fail to arrest or differentiate when cultured in differentiation medium (DM). To determine the basis for the failure of RMS cells to differentiate or arrest, we studied the molecular response of the embryonal RMS cell line, RD, to culture in DM. Under these conditions, the retinoblastoma protein (RB) was primarily in the hyperphosphorylated state. This is in contrast to myoblasts cultured in DM, in which the hypophosphorylated form of RB is exclusively present. Measurements of the expression and activities of cyclin-dependent kinases (cdks) cdk2 and cdk4 indicated that RD cells maintained higher levels than do myoblasts, and the activity and abundance of these proteins did not significantly decrease upon culture in DM in RD cells, as they did in myoblasts. Similarly, elevated expression of cyclins D1, E, and A was observed in RD cells. Interestingly, cdk inhibitors are expressed in RD cells, with p16ink4 expression markedly elevated relative to myoblasts. Ectopic expression of p21cip1, p16ink4, or p27kip1 caused a growth arrest of RD cells but not detectable expression of a myogenic marker. Furthermore, a constitutively active RB protein could also inhibit the growth of RD cells without inducing myogenic differentiation. Taken together, these data suggest that the elevated levels of cdk2 and/or cdk4 observed in RD cells contribute to the inability of RD cells to growth arrest when cultured in DM but that these activities alone are not responsible for the failure of RD cells to differentiate.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9581851

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  11 in total

1.  CIITA is silenced by epigenetic mechanisms that prevent the recruitment of transactivating factors in rhabdomyosarcoma cells.

Authors:  Priya Londhe; Bo Zhu; Jinu Abraham; Charles Keller; Judith Davie
Journal:  Int J Cancer       Date:  2012-01-11       Impact factor: 7.396

2.  Induction of terminal differentiation by constitutive activation of p38 MAP kinase in human rhabdomyosarcoma cells.

Authors:  P L Puri; Z Wu; P Zhang; L D Wood; K S Bhakta; J Han; J R Feramisco; M Karin; J Y Wang
Journal:  Genes Dev       Date:  2000-03-01       Impact factor: 11.361

3.  The ablation of EZH2 uncovers its crucial role in rhabdomyosarcoma formation.

Authors:  Irene Marchesi; Francesco Paolo Fiorentino; Flavio Rizzolio; Antonio Giordano; Luigi Bagella
Journal:  Cell Cycle       Date:  2012-09-14       Impact factor: 4.534

4.  TBX2 blocks myogenesis and promotes proliferation in rhabdomyosarcoma cells.

Authors:  Bo Zhu; Meiling Zhang; Stephanie D Byrum; Alan J Tackett; Judith K Davie
Journal:  Int J Cancer       Date:  2014-01-27       Impact factor: 7.396

Review 5.  Delineation of the androgen-regulated signaling pathways in prostate cancer facilitates the development of novel therapeutic approaches.

Authors:  Dominik Awad; Thomas L Pulliam; Chenchu Lin; Sandi R Wilkenfeld; Daniel E Frigo
Journal:  Curr Opin Pharmacol       Date:  2018-03-30       Impact factor: 5.547

6.  The myogenic kinome: protein kinases critical to mammalian skeletal myogenesis.

Authors:  James Dr Knight; Rashmi Kothary
Journal:  Skelet Muscle       Date:  2011-09-08       Impact factor: 4.912

7.  p21WAF1 expression induced by MEK/ERK pathway activation or inhibition correlates with growth arrest, myogenic differentiation and onco-phenotype reversal in rhabdomyosarcoma cells.

Authors:  Carmela Ciccarelli; Francesco Marampon; Arianna Scoglio; Annunziata Mauro; Cristina Giacinti; Paola De Cesaris; Bianca M Zani
Journal:  Mol Cancer       Date:  2005-12-13       Impact factor: 27.401

8.  Chinese medicinal herb, Acanthopanax gracilistylus, extract induces cell cycle arrest of human tumor cells in vitro.

Authors:  B E Shan; K Zeki; T Sugiura; Y Yoshida; U Yamashita
Journal:  Jpn J Cancer Res       Date:  2000-04

9.  Loss of MEF2D expression inhibits differentiation and contributes to oncogenesis in rhabdomyosarcoma cells.

Authors:  Meiling Zhang; Jamie Truscott; Judith Davie
Journal:  Mol Cancer       Date:  2013-11-27       Impact factor: 27.401

10.  Uremic toxins enhance statin-induced cytotoxicity in differentiated human rhabdomyosarcoma cells.

Authors:  Hitoshi Uchiyama; Masayuki Tsujimoto; Tadakazu Shinmoto; Hitomi Ogino; Tomoko Oda; Takuya Yoshida; Taku Furukubo; Satoshi Izumi; Tomoyuki Yamakawa; Hidehisa Tachiki; Tetsuya Minegaki; Kohshi Nishiguchi
Journal:  Toxins (Basel)       Date:  2014-09-03       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.